The Scientific Frontier

Medical Research

6 articles

A glowing petri dish in a dark laboratory, symbolizing a retracted scientific study on morning cancer therapy.
Cosmos & Physics

Study on Morning Cancer Therapy Effectiveness Retracted Due to Flaws

A paper in Nature Medicine , which suggested non-small cell lung cancer patients could benefit from morning immunotherapy, has been formally retracted following a four-month investigation, according t

Dr. Evelyn Reed·June 25, 2026
Dusty, forgotten Ebola vaccine vials sit on a shelf in a dimly lit laboratory, symbolizing stalled progress and lost potential.
Cosmos & Physics

Ebola vaccine sits on shelf 15 years due to systemic failures

A 2011 vaccine candidate demonstrated 100% protection in macaques against the Bundibugyo Ebola strain, yet it has never been deployed in humans, leaving communities vulnerable to ongoing outbreaks.

Dr. Evelyn Reed·June 20, 2026
Microscopic view of autoantibodies attacking neural pathways in a mouse brain, illustrating the neurological impact of Long COVID.
Cosmos & Physics

Long COVID Autoantibodies Attack Brain, Nervous System in Mice

Transferring antibodies from long COVID patients into healthy mice induced increased pain sensitivity, fatigue, impaired balance, and damage to small nerve fibers, as reported by Pharmexec .

Dr. Evelyn Reed·June 1, 2026
Advanced gene editing technology in a lab setting, symbolizing the manipulation of DNA to improve cardiovascular health and lower cholesterol levels.
Cosmos & Physics

Verve gene editor lowers cholesterol in new study

A single infusion of Verve's experimental gene editor, VERVE-102, slashed patients' LDL cholesterol by 62% in a recent study, offering a potential one-time solution for a lifelong condition.

Dr. Evelyn Reed·May 25, 2026
Microscopic view of senescent cells being identified by glowing blue aptamer molecules in a laboratory setting, representing a breakthrough in longevity research.
Health & Medicine

Scientists use aptamers to identify aging cells in longevity research

A low-dose, 1mg/day regimen of rapamycin improved diastolic heart function in older men in just eight weeks, according to gethealthspan .

Maria Flores·May 19, 2026
A glowing, complex quintuple agonist molecule in a futuristic lab, representing a breakthrough in obesity and diabetes treatment.
Cosmos & Physics

New Quintuple Agonist Shows Promise for Obesity and Diabetes in Mice

In obese mice, a single experimental drug molecule, a GLP-1R GIPR PPAR quintuple agonist, led to greater weight loss and better blood sugar control than semaglutide (Ozempic) and a standard GLP-1/GIP

Dr. Evelyn Reed·May 18, 2026